Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Manuscripts exploring glycans in the broadest sense, such as basic, translational, and applied glycobiology research fall within the scope of this collection.
In this cross-journal Collection between Nature Communications, Communications Medicine, and Scientific Reports we invite submission of clinical trials.
This cross-journal collection welcomes submissions of clinical and preclinical work on innovative methods for treating all mental disorders, including major depressive disorder, anxiety disorder, schizophrenia, eating disorder, substance use disorder, and post-traumatic stress disorder.
This Collection aims to collate the latest advances in computational method development for drug discovery and medicinal chemistry, as well as their application in preclinical studies.
With this collection we invite primary research articles and clinical reports that focus on the metabolic state of immune cells and metabolic regulation of immune responses in health or in disease.
This cross-journal Collection welcomes submissions that explore all aspects of dementia, including incidence, prevention, diagnosis and treatment of dementia and the impact on carers and society.
This Collection welcomes submissions related to a broad range of topics within reproductive health care and medicine related to reproductive well-being.
This cross-journal Collection welcomes submissions that explore stem cell biology, their therapeutic potential, and the use of stem cells and stem cell-derived products to treat human disease.
In this cross-journal collection between Nature Communications, Communications Medicine, Communications Biology, and Scientific Reports, we invite submissions with a focus on cancer-host reciprocal interactions that go beyond cancer-tumour microenvironment interactions.
